Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa

• Karen Shean,

  Affiliation Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Elizabeth Streicher,

  Affiliation DST/NRF Centre of Excellence for Biomedical TB Research/MRC Centre for Molecular and Cellular Biology, Stellenbosch University, Stellenbosch, South Africa

  ⨯
• Elize Pieterson,

  Affiliation Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Greg Symons,

  Affiliation Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Richard van Zyl Smit,

  Affiliation Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Grant Theron,

  Affiliation Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Rannakoe Lehloenya,

  Affiliation Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Xavier Padanilam,

  Affiliations Sizwe Tropical Diseases Hospital, Sandringham, Johannesburg, South Africa, Division of Infectious Diseases, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Paul Wilcox,

  Affiliation Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Tommie C. Victor,

  Affiliation DST/NRF Centre of Excellence for Biomedical TB Research/MRC Centre for Molecular and Cellular Biology, Stellenbosch University, Stellenbosch, South Africa

  ⨯
• Paul van Helden,

  Affiliation DST/NRF Centre of Excellence for Biomedical TB Research/MRC Centre for Molecular and Cellular Biology, Stellenbosch University, Stellenbosch, South Africa

  ⨯
• Martin Groubusch,

  Affiliations Sizwe Tropical Diseases Hospital, Sandringham, Johannesburg, South Africa, National Health Laboratory Service and Division of Clinical Microbiology and Infectious Diseases, University of Witwatersrand, Johannesburg, South Africa, Division of Infectious Diseases, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Amsterdam Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Robin Warren,

  Affiliation DST/NRF Centre of Excellence for Biomedical TB Research/MRC Centre for Molecular and Cellular Biology, Stellenbosch University, Stellenbosch, South Africa

  ⨯
• Motasim Badri,

  Affiliations Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

  ⨯
• Keertan Dheda

  * E-mail: keertan.dheda@uct.ac.za

  Affiliations Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Department of Infection, University College London Medical School, London, United Kingdom

  ⨯